You are here

Article Text

Article menu
Download PDFPDF
Adult nursing
Randomised controlled trial
Earlier thrombolytic treatment is associated with better outcomes following acute ischaemic stroke
  1. Naseeb Ullah,
  2. Michelle J Thompson,
  3. Adnan I Qureshi
  1. Zeenat Qureshi Stroke Institute and Department of Cerebrovascular Diseases, Centracare Health, St Cloud, MN, USA
  1. Correspondence to : Dr Adnan I Qureshi, 420 Delaware St, SE Minneapolis, MN 55455, USA; aiqureshi{at}hotmail.com

https://doi.org/10.1136/eb-2013-101506

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischaemic stroke, JAMA 2013;309:2480–8.OpenUrlCrossRefPubMedWeb of Science

    Implications for practice and research

    • Optimisation is necessary in public education and hospital triage of the identification of factors such as arrival by ambulance and the importance of requesting emergency medical services (EMS) at scene of the stroke occurrence.1

    • The results of previous studies suggest that a disparity, observed between hospital-based outcomes for admissions that presented during regular hours and off hours, is not seen in all settings and so is a modifiable factor.2

    Context

    The benefit of intravenous recombinant tissue plasminogen activator (rt-PA) in acute ischaemic stroke is time-dependent. Saver and colleagues analysed data from patients in hospitals …

    View Full Text

    Footnotes

    • Competing interests None.